Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Third party request |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-01-04 |
| Study Made Public: | 2015-09-17 |
Title
NHP Study P162 - a recapitulation of RV144 in NHP, with alternate adjuvants and boosting with differing protein constructs
Description
CAVD 405 (NHP Study P162) is a non-human primate challenge study of ALVAC/protein prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
Alum MF59 SIVmac251 None gD-766gp120 gD-CG7Vgp120 ALVAC parental ALVAC-SIV 766 Gag-pro-SIV 766gp120-TM ALVAC-SIV K6W SC 766 SC CG7V SIV mac251 proteinIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.